Clonmel, Ireland

Liam Corcoran

This inventor holds 1 USPTO granted patent and 2 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Portola Pharmaceuticals, Inc.. Active years: 2015.

USPTO Granted Patents = 1 

% Patents Active = 100.0


 

Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2015

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Liam Corcoran

Introduction

Liam Corcoran is a notable inventor based in Clonmel, Ireland. He has made significant contributions to the field of pharmaceuticals, particularly in the development of factor Xa inhibitors. His work has implications for various therapeutic applications, showcasing his expertise and dedication to innovation.

Latest Patents

Liam holds a patent for "Crystalline forms of a factor Xa inhibitor." This patent provides crystalline forms of a maleate salt of betrixaban, along with compositions and methods of preparation or use thereof. His innovative approach in this area highlights the importance of developing effective anticoagulant therapies.

Career Highlights

Liam Corcoran is currently employed at Portola Pharmaceuticals, Inc., where he continues to advance his research and development efforts. His work at this company has positioned him as a key player in the pharmaceutical industry, contributing to the development of critical medications.

Collaborations

Liam has collaborated with notable colleagues, including Richard G Ball and Eric L Margelefsky. These partnerships have fostered a collaborative environment that enhances the innovation process and leads to groundbreaking discoveries.

Conclusion

Liam Corcoran's contributions to the field of pharmaceuticals, particularly through his patent on factor Xa inhibitors, demonstrate his commitment to innovation and excellence. His work continues to impact the industry positively, paving the way for future advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…